Yafit Segman, MD

Hematology Institute, Samson Assuta Ashdod University Hospital, Ashdod, and the faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel, Israel

Poster(s):

• (2654) International Multi-Center Study Comparing the Effect of Obinutuzumab or Rituximab Treatment in Hematological Patients on COVID-19 Outcomes During the Omicron Surge
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET